Total Pageviews

Fibrous dysplasia is characterized by all EXCEPT: (PSC - Lumbini 2083)

# Fibrous dysplasia is characterized by all EXCEPT: (PSC - Lumbini 2083)
A. Involvement of several bones
B. Enlargement of the affected bones
C. Associated with non-vital teeth
D. Displacement of teeth



Fibrous dysplasia is a developmental, benign fibro-osseous bone condition characterized by the replacement of normal cancellous bone with cellular fibrous connective tissue and poorly formed woven bone.

To answer this MCQ meticulously, let's evaluate each option based on the clinical, radiographic, and histological behavior of the lesion:

  • A. Involvement of several bones: True. Fibrous dysplasia can present in three primary clinical patterns: monostotic (involving a single bone), polyostotic (involving multiple bones), and McCune-Albright syndrome (polyostotic involvement with endocrinopathies and cafĂ©-au-lait pigmentation).

  • B. Enlargement of the affected bones: True. As the proliferating fibro-osseous mass replaces normal bone architecture, it leads to a slow, painless, and progressive bony expansion, which often results in noticeable facial asymmetry when the maxilla or mandible is involved.

  • D. Displacement of teeth: True. The expansile nature of the lesion commonly causes bodily displacement or migration of adjacent teeth, disrupting the occlusal plane and leading to malocclusion. (Note: Root resorption is relatively rare, but displacement is a hallmark).

  • C. Associated with non-vital teeth: False. This is the exception. The teeth involved within or adjacent to a fibrous dysplasia lesion retain their normal neurovascular supply and remain vital. Loss of pulp vitality is typically associated with endodontic pathology, radicular cysts, or aggressive malignancies, rather than a developmental fibro-osseous defect. Pulp vitality testing in a purely fibrous dysplasia-affected segment will yield normal responses.

The first-line drug for acute myocardial infarction in dental emergency is: (PSC - Lumbini 2083)

 # The first-line drug for acute myocardial infarction in dental emergency is: (PSC - Lumbini 2083)
 A. Nitroglycerin
B. Aspirin
C. Atorvastatin
D. Metoprolol



The correct answer is B. Aspirin.

In a dental emergency setting, the pharmacological priority for an acute myocardial infarction (AMI) is halting the expansion of the coronary thrombus:

Aspirin: This is the definitive first-line therapeutic drug for a suspected AMI. Standard protocol mandates the immediate administration of 160–325 mg of non-enteric-coated, chewable aspirin. It acts as a rapid antiplatelet agent by irreversibly inhibiting the cyclooxygenase-1 (COX-1) enzyme, blocking the synthesis of thromboxane A2. This prevents further platelet aggregation and is the primary chairside intervention proven to reduce patient mortality.   

Nitroglycerin: While sublingual Nitroglycerin (0.4 mg) is the first-line emergency drug for angina pectoris, it is not the primary disease-modifying drug for an established infarction. During an AMI, it provides symptomatic pain relief by acting as a vasodilator that reduces venous return (preload) and myocardial oxygen demand, but it does not stop the underlying thrombotic event.   

Atorvastatin & Metoprolol: These are critical hospital-administered medications utilized following an MI, but they are not acute, first-line emergency drugs kept in a standard clinical emergency armamentarium.

Which anticoagulant is most commonly monitored using INR? (PSC - Lumbini 2083)

 # Which anticoagulant is most commonly monitored using INR? (PSC - Lumbini 2083)
A. Aspirin
B. Heparin
C. Warfarin
D. Clopidogrel



The correct answer is C. Warfarin.

 Warfarin is a Vitamin K antagonist whose therapeutic efficacy and bleeding risk must be routinely monitored using the International Normalized Ratio (INR). Antiplatelets (like Aspirin and Clopidogrel) do not require routine INR monitoring. 

The first line drug for anaphylaxis is: (PSC - Lumbini 2083)

 # The first line drug for anaphylaxis is: (PSC - Lumbini 2083)
A. Diphenhydramine
B. Epinephrine
C. Hydrocortisone
D. Oxygen


The correct answer is B. Epinephrine.

Intramuscular epinephrine (typically 0.3 to 0.5 mg of a 1:1,000 solution injected into the anterolateral thigh) is the absolute first-line drug of choice. It acts as a physiological antagonist to systemic mediators of anaphylaxis, reversing peripheral vasodilation, reducing tissue edema, and inducing bronchodilation.

Popular Posts